Use of acemannan for the treatment of multiple sclerosis and for the correction of malabsorption

摘要

The use of acemannan for the manufacture of a medicament for a vaccine adjuvant, for the production of a defective virus, for the treatment of an inflammatory bowel disease, for the correction of mucosal cell maturation syndromes, for the treatment of multiple sclerosis, and for the correction of malabsorption. A method of producing a defective virus in master seed cultures for vaccine production comprising the addition of a pharmaceutically effective amount of acemannan to a master seed culture to produce altered viral replication.